Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal pharmacodynamics--basic principles. II: Drug action and elimination

B L Ohning

    Neonatal Network : NN
    |March 1, 1995
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Neonatal pharmacodynamics--basic principles. I: Drug delivery.

    Neonatal network : NN·1995
    Same author

    Randomized, controlled trial of nasopharyngeal continuous positive airway pressure in the extubation of very low birth weight infants.

    The Journal of pediatrics·1994
    Same author

    Reversible obstructive hypertrophic cardiomyopathy after dexamethasone therapy for bronchopulmonary dysplasia.

    American heart journal·1993
    Same author

    The disposition of alfentanil in neonates with respiratory distress.

    Pharmacotherapy·1991
    Same author

    Biophysical and biological activity of a synthetic 8.7-kDa hydrophobic pulmonary surfactant protein SP-B.

    Proceedings of the National Academy of Sciences of the United States of America·1990
    Same author

    Structural relationships of the major glycoproteins from human alveolar proteinosis surfactant.

    Biochimica et biophysica acta·1987

    This review simplifies key pharmacologic principles for neonatal care, focusing on drug action mechanisms, liver metabolism, and kidney excretion in newborns. It covers elimination half-life, clearance, and consequences of overwhelmed elimination pathways.

    Area of Science:

    • Neonatal pharmacology
    • Clinical drug disposition
    • Pediatric pharmacokinetics

    Background:

    • Understanding drug behavior in neonates is crucial for safe and effective treatment.
    • Neonatal patients present unique challenges due to immature organ systems affecting drug processing.
    • Pharmacokinetics and pharmacodynamics are essential for optimizing drug therapy in this population.

    Purpose of the Study:

    • To summarize critical pharmacologic principles for clinicians managing neonatal patients.
    • To simplify and present six key principles of drug action and elimination for improved recall.
    • To detail drug mechanisms, hepatic biotransformation, and renal excretion in neonates.

    Main Methods:

    • Review of established pharmacokinetic and pharmacodynamic principles.

    Related Experiment Videos

  • Focus on the final three of six simplified pharmacologic concepts.
  • Discussion of drug elimination pathways, half-life, and clearance in the neonatal context.

    • Main Results:

    • Explanation of drug action mechanisms.
    • Overview of hepatic drug metabolism (biotransformation) in neonates.
    • Details on renal drug elimination, including half-life and clearance.

    Conclusions:

    • Neonatal drug elimination is influenced by immature liver and kidney functions.
    • Understanding drug half-life and clearance is vital for neonatal dosing.
    • Overwhelmed elimination can result from drug excess or neonatal immaturity, impacting patient safety.